Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06734026 · ClinicalTrials.gov registry record · NA
Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury
A NA study of Traumatic Brain Injury (TBI) Patients, sponsored by MetroHealth Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06734026: Recruiting NA study of Traumatic Brain Injury (TBI) Patients, sponsored by MetroHealth Medical Center.
NCT06734026 is a NA study of Traumatic Brain Injury (TBI) Patients that is actively recruiting participants, run by MetroHealth Medical Center. The registered enrollment target is 20 participants, below the 191-participant average among 4 other Traumatic Brain Injury (TBI) Patients trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06734026, a NA study of Traumatic Brain Injury (TBI) Patients, is actively recruiting participants, sponsored by MetroHealth Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn if a enhanced environment (Metro Café) with multi model approach (an approach that combines several therapies) in chronic traumatic brain injury improves outcomes of recovery better than traditional therapy. The main questions it aims to answer are: * Determine the amount of therapy dosage (speech, cognition, arm and leg movements) obtained during the Metro Café therapy session. * Evaluate the connection between environmental enrichment dosage (the Metro Café) and clinical outcome scores. Researchers will compare Metro Café Treatment to those who do not receive this treatment to see if better improvements in function after a traumatic brain injury are seen in the Metro Café Treatment Participants will train in the Metro Cafe during the 2-month gap between assessments, for a total of 18 training sessions, each up to 2 hours, 3 times per week. Participants will greet and serve customers drinks and snacks, maintain food supplies at the counters and performs housekeeping tasks with advice and assistance from a supervising researcher as needed,
Primary Outcome
Preprocessing of data will be performed, and motion data will then be extracted. We will evaluate motion by single limb, namely: right arm, right leg, left arm, left leg. We will also combine across limbs: right arm, left arm, right leg, left leg, and over the whole-body amount of motion (AoM).
Conditions Studied
Interventions
- BEHAVIORAL Cafe Therapy
Study Locations (1)
Ohio
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-04-08 |
| Est. Completion | 2029-01-15 |
| Phase | NA |
What NCT06734026 shows while recruiting
NCT06734026 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 191-participant average among 4 other Traumatic Brain Injury (TBI) Patients trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Traumatic Brain Injury (TBI) Patients appearing as the primary indexed condition, and to 1 intervention - of which Cafe Therapy is the first listed.
NCT06734026 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06734026 about?
NCT06734026 is a clinical study titled "Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury". The goal of this study is to learn if a enhanced environment (Metro Café) with multi model approach (an approach that combines several therapies) in chronic traumatic brain injury improves outcomes of recovery better than traditional therapy. The main questions it aims to answer are: * Determine th...
What is the current status of trial NCT06734026?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-04-08. Estimated completion is 2029-01-15.
What conditions does trial NCT06734026 study?
This clinical trial studies the following conditions: Traumatic Brain Injury (TBI) Patients.
What interventions are being tested in trial NCT06734026?
The interventions under investigation include: Cafe Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06734026?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06734026 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury (TBI) Patients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcutaneous Vagus Nerve Stimulation for Attention and Memory
RECRUITING · NA
-
Early Neuromodulation in Traumatic Brain Injury
RECRUITING · NA
-
External Post-Operative Skull Prosthesis to Prevent Sunken Flap Syndrome in Craniectomy Patients
RECRUITING · NA
-
Saline Versus Balanced Crystalloid in Traumatic Brain Injury
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI